Tetrabutylammonium prolinate-based ionic liquids: A combined asymmetric catalysis, antimicrobial toxicity and biodegradation assessment
Research output: Journal contributions › Journal articles › Research › peer-review
Standard
In: RSC Advances, Vol. 3, No. 48, 28.12.2013, p. 26241-26251.
Research output: Journal contributions › Journal articles › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Tetrabutylammonium prolinate-based ionic liquids
T2 - A combined asymmetric catalysis, antimicrobial toxicity and biodegradation assessment
AU - Ferlin, Nadege
AU - Courty, Matthieu
AU - Van Nhien, Albert Nguyen
AU - Gatard, Sylvain
AU - Pour, Milan
AU - Quilty, Bríd
AU - Ghavre, Mukund
AU - Haiß, A.
AU - Kümmerer, K.
AU - Gathergood, Nicholas
AU - Bouquillon, Sandrine
N1 - This work was supported by the Fondation du Site Paris Reims (post doctoral fellowship for Nad`ege Ferlin) and the FEDER for material funds. This work was also supported by Enterprise Ireland (EI TD/07/328, Ian Beadham and Mukund Ghave). The antibacterial and antifungal screening was supported by the Czech Science Foundation (project no. P207/10/2048) (Milan Pour, 20 Strains).
PY - 2013/12/28
Y1 - 2013/12/28
N2 - Chiral ionic liquids (CILs) tetrabutylammonium-(S)-prolinate, tetrabutylammonium-(R)-prolinate and tetrabutylammonium trans-4-hydroxy-(S)- prolinate were investigated as chiral additives in the Pd-catalyzed enantioselective hydrogenation of α,β-unsaturated ketones. These CILs were easily prepared in one step from the aminoacid and tetrabutylammonium hydroxide and characterized (NMR, IR, optical rotation, elemental analysis, DSC, viscosity, decomposition temperature). The research strategy was to assess the antimicrobial toxicity (>20 strains) and biodegradability (OECD 301D) of the CILs at the same time as undertaking the asymmetric catalysis study. The Pd-catalyzed enantioselective hydrogenation of the carbon-carbon double bond of α,β-unsaturated ketones under mild conditions (room temperature, 1 atm of H 2) in different solvents with CILs present. The best results were obtained in i-PrOH after 18 hours of reaction with a i-PrOH/IL ratio of 5. While all three CILs have low antimicrobial toxicity to a wide range of bacteria and fungi, tetrabutylammonium-(S)-prolinate, tetrabutylammonium-(R)-prolinate and tetrabutylammonium trans-4-hydroxy-(S)-prolinate did not pass the Closed Bottle biodegradation test.
AB - Chiral ionic liquids (CILs) tetrabutylammonium-(S)-prolinate, tetrabutylammonium-(R)-prolinate and tetrabutylammonium trans-4-hydroxy-(S)- prolinate were investigated as chiral additives in the Pd-catalyzed enantioselective hydrogenation of α,β-unsaturated ketones. These CILs were easily prepared in one step from the aminoacid and tetrabutylammonium hydroxide and characterized (NMR, IR, optical rotation, elemental analysis, DSC, viscosity, decomposition temperature). The research strategy was to assess the antimicrobial toxicity (>20 strains) and biodegradability (OECD 301D) of the CILs at the same time as undertaking the asymmetric catalysis study. The Pd-catalyzed enantioselective hydrogenation of the carbon-carbon double bond of α,β-unsaturated ketones under mild conditions (room temperature, 1 atm of H 2) in different solvents with CILs present. The best results were obtained in i-PrOH after 18 hours of reaction with a i-PrOH/IL ratio of 5. While all three CILs have low antimicrobial toxicity to a wide range of bacteria and fungi, tetrabutylammonium-(S)-prolinate, tetrabutylammonium-(R)-prolinate and tetrabutylammonium trans-4-hydroxy-(S)-prolinate did not pass the Closed Bottle biodegradation test.
KW - Chemistry
KW - Asymmetric catalysis
KW - Carbon-carbon double bonds
KW - Chiral ionic liquids
KW - Closed bottle biodegradation tests
KW - Decomposition temperature
KW - Enantioselective hydrogenation
KW - Tetrabutylammonium hydroxides
KW - Unsaturated ketones
UR - http://www.scopus.com/inward/record.url?scp=84887954290&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/6772485b-68b9-36ba-ae02-e65574096761/
U2 - 10.1039/c3ra43785j
DO - 10.1039/c3ra43785j
M3 - Journal articles
AN - SCOPUS:84887954290
VL - 3
SP - 26241
EP - 26251
JO - RSC Advances
JF - RSC Advances
SN - 2046-2069
IS - 48
ER -